Abstract
Purpose
Large Rathke’s cleft cysts (LRCCs) and cystic craniopharyngiomas (CCPs) arise from the same embryological origin and may have similar MR presentations. However, the two tumors have different management strategies and outcomes. This study was designed to evaluate the clinical and imaging findings of LRCCs and CCPs, aiming to evaluate their pretreatment diagnosis and outcomes.
Methods
We retrospectively enrolled 20 patients with LRCCs and 25 patients with CCPs. Both tumors had a maximal diameter of more than 20 mm. We evaluated the patients’ clinical and MR imaging findings, including symptoms, management strategies, outcomes, anatomic growth patterns and signal changes.
Results
The age of onset for LRCCs versus CCPs was 49.0 ± 16.8 versus 34.2 ± 22.2 years (p = .022); the following outcomes were observed for LRCCs versus CCPs: (1) postoperative diabetes insipidus: 6/20 (30%) versus 17/25 (68%) (p = .006); and (2) posttreatment recurrence: 2/20 (10%) versus 10/25 (40%) (p = .025). The following MR findings were observed for LRCCs versus CCPs: (1) solid component: 7/20 (35%) versus 21/25 (84%) (p = .001); (2) thick cyst wall: 2/20 (10%) versus 12/25 (48%) (p = .009); (3) intracystic septation: 1/20 (5%) versus 8/25 (32%) (p = .030); (4) snowman shape: 18/20 (90%) versus 1/25 (4%) (p < .001); (5) off-midline extension: 0/0 (0%) versus 10/25 (40%) (p = .001); and (6) oblique angle of the sagittal long axis of the tumor: 89.9° versus 107.1° (p = .001).
Conclusions
LRCCs can be differentiated from CCPs based on their clinical and imaging findings, especially their specific anatomical growth patterns. We suggest using the pretreatment diagnosis to select the appropriate surgical approach and thus improve the clinical outcome.Keywords: Rathke’s cleft cyst, craniopharyngioma, sellar mass, magnetic resonance imaging.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
References
Potts MB, Jahangiri A, Lamborn KR, Blevins LS, Kunwar S, Aghi MK (2011) Suprasellar Rathke cleft cysts: clinical presentation and treatment outcomes. Neurosurgery 69(5):1058–1068. https://doi.org/10.3389/fgene.2018.00049
Han SJ, Rolston JD, Jahangiri A, Aghi MK (2014) Rathke’s cleft cysts: review of natural history and surgical outcomes. J Neurooncol 117(2):197–203. https://doi.org/10.1007/s11060-013-1272-6
Zada G (2011) Rathke cleft cysts: a review of clinical and surgical management. Neurosurg Focus 31(1):E1. https://doi.org/10.3171/2011.5.FOCUS1183
Naik VD, Thakore NR (2013) A case of symptomatic Rathke’s cyst. BMJ Case Rep 2013:bcr2012006943. https://doi.org/10.1136/bcr-2012-006943
Andrysiak-Mamos E, Sagan K, Sagan L, Sowinska-Przepiera E, Syrenicz A (2018) Cystic lesions of the sellar-suprasellar region—diagnosis and treatment. Endokrynol Pol 69(2):212–228. https://doi.org/10.5603/EP.2018.0023
Garnett MR, Puget S, Grill J, Sainte-Rose C (2007) Craniopharyngioma. Orphanet J Rare Dis 2:18. https://doi.org/10.1186/1750-1172-2-18
Harrison MJ, Morgello S, Post KD (1994) Epithelial cystic lesions of the sellar and parasellar region: a continuum of ectodermal derivatives? J Neurosurg 80(6):1018–1025. https://doi.org/10.3171/jns.1994.80.6.1018
Fujio S, Hanada T, Yonenaga M et al (2021) Surgical aspects in craniopharyngioma treatment. Innov Surg Sci 6(1):25–33. https://doi.org/10.1515/iss-2019-1004
Muller HL (2020) The diagnosis and treatment of craniopharyngioma. Neuroendocrinology 110(9–10):753–766. https://doi.org/10.1159/000504512
Isono M, Kamida T, Kobayashi H, Shimomura T, Matsuyama J (2001) Clinical features of symptomatic Rathke’s cleft cyst. Clin Neurol Neurosurg 103(2):96–100. https://doi.org/10.1016/s0303-8467(01)00121-4
Muller HL (2014) Craniopharyngioma. Endocr Rev 35(3):513–543. https://doi.org/10.1210/er.2013-1115
Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90(2):237–250. https://doi.org/10.3171/jns.1999.90.2.0237
Aho CJ, Liu C, Zelman V, Couldwell WT, Weiss MH (2005) Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg 102(2):189–193. https://doi.org/10.3171/jns.2005.102.2.0189
Kinoshita Y, Taguchi A, Yamasaki F, Tominaga A, Arita K, Horie N (2022) Natural course of Rathke’s cleft cysts and risk factors for progression. J Neurosurg. https://doi.org/10.3171/2022.7.JNS22716
Turel MK, Tsermoulas G, Gonen L et al (2016) Management and outcome of recurrent adult craniopharyngiomas: an analysis of 42 cases with long-term follow-up. Neurosurg Focus 41(6):E11. https://doi.org/10.3171/2016.9.FOCUS16315
Yano S, Kudo M, Hide T et al (2016) Quality of life and clinical features of long-term survivors surgically treated for pediatric craniopharyngioma. World Neurosurg 85:153–162. https://doi.org/10.1016/j.wneu.2015.08.059
Kilic M, Can SM, Ozdemir B, Tanik C (2019) Management of craniopharyngioma. J Craniofac Surg 30(2):e178–e183. https://doi.org/10.1097/scs.0000000000005136
Byun WM, Kim OL, Kim D (2000) MR imaging findings of Rathke’s cleft cysts: significance of intracystic nodules. AJNR Am J Neuroradiol 21(3):485–488
Wang S, Nie Q, Wu Z, Zhang J, Wei L (2020) MRI and pathological features of Rathke cleft cysts in the sellar region. Exp Ther Med 19(1):611–618. https://doi.org/10.3892/etm.2019.8272
Park M, Lee SK, Choi J et al (2015) Differentiation between cystic pituitary adenomas and rathke cleft cysts: a diagnostic model using MRI. AJNR Am J Neuroradiol 36(10):1866–1873. https://doi.org/10.3174/ajnr.a4387
Tosaka M, Sato N, Hirato J et al (2007) Assessment of hemorrhage in pituitary macroadenoma by T2*-weighted gradient-echo MR imaging. AJNR Am J Neuroradiol 28(10):2023–2029. https://doi.org/10.3174/ajnr.A0692
Kumar S, Kumar A, Gill MS, Maheshwari V (2019) Optic tract edema: a rare entity in pituitary macroadenoma. Asian J Neurosurg 14(1):307–309. https://doi.org/10.4103/ajns.AJNS_178_18
Choi SH, Kwon BJ, Na DG, Kim JH, Han MH, Chang KH (2007) Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI. Clin Radiol 62(5):453–462. https://doi.org/10.1016/j.crad.2006.12.001
Kunii N, Abe T, Kawamo M, Tanioka D, Izumiyama H, Moritani T (2007) Rathke’s cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging. Acta Neurochir (Wien) 149(8):759–769. https://doi.org/10.1007/s00701-007-1234-x
Kinoshita Y, Yamasaki F, Tominaga A et al (2016) Diffusion-weighted imaging and the apparent diffusion coefficient on 3T MR imaging in the differentiation of craniopharyngiomas and germ cell tumors. Neurosurg Rev 39(2):207–213. https://doi.org/10.1007/s10143-015-0660-0
Morisako H, Goto T, Goto H, Bohoun CA, Tamrakar S, Ohata K (2016) Aggressive surgery based on an anatomical subclassification of craniopharyngiomas. Neurosurg Focus 41(6):E10. https://doi.org/10.3171/2016.9.focus16211
Karavitaki N, Brufani C, Warner JT et al (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62(4):397–409. https://doi.org/10.1111/j.1365-2265.2005.02231.x
Meyer JR, Quint DJ, McKeever PE, Boland M, Ross DA (1994) Giant Rathke cleft cyst. AJNR Am J Neuroradiol 15(3):533–536
Mahmoud OM, Tominaga A, Amatya VJ et al (2010) Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions. Eur J Radiol 74(3):420–427. https://doi.org/10.1016/j.ejrad.2009.03.031
Gadelha MR, Wildemberg LE, Lamback EB, Barbosa MA, Kasuki L, Ventura N (2022) Approach to the patient: differential diagnosis of cystic sellar lesions. J Clin Endocrinol Metab 107(6):1751–1758. https://doi.org/10.1210/clinem/dgac033
Alomari AK, Kelley BJ, Damisah E et al (2015) Craniopharyngioma arising in a Rathke’s cleft cyst: case report. J Neurosurg Pediatr 15(3):250–254. https://doi.org/10.3171/2014.11.peds14370
Funding
This study has received funding from Taipei Veterans General Hospital, Taiwan [V111B-032, V112B-007 (to CHW); V110C-037, V111C-028, V112C-059, V112D67-002-MY3-1 (to FCC); V112B-005 (to STC); V112B-032 (to TML)], Veterans General Hospitals and University System of Taiwan Joint Research Program [VGHUST 109V1-5-2 and VGHUST 110-G1-5-2 (to FCC)], Ministry of Science and Technology (National Science and Technology Council) of Taiwan [MOST 110-2314-B-075-005- and 111-2314-B-075-025-MY3 (to CHW); MOST 109-2314-B-075-036 and 110-2314-B-075-032 (to FCC); MOST 110-2314-B-075-035-MY2 (to STC)], Yen Tjing Ling Medical Foundation, Taiwan [CI-109-3, CI-111-2, CI-112-2 (to CHW)], Professor Tsuen CHANG’s Scholarship Program from Medical Scholarship Foundation In Memory Of Professor Albert Ly-Young Shen (to CHW) and Vivian W. Yen Neurological Foundation (to CHW and FCC).
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
This study was approved by the Institutional Review Board of our hospital and followed all applicable laws, regulations, and policies for the protection of human participants.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yang, CH., Wu, CH., Lin, TM. et al. Clinical and imaging findings for the evaluation of large Rathke’s cleft cysts and cystic craniopharyngiomas. Pituitary 26, 393–401 (2023). https://doi.org/10.1007/s11102-023-01326-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-023-01326-3